SCHEMBL14922328

SCHEMBL14922328

CN1CCN(c2ccc(N[SH](=O)=O)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.52
▸ ADRA2C P18825 3/20 0.52
▸ GAA P10253 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ MAPT P10636 1/20 0.52
▸ GFER P55789 1/20 0.52
▸ PTK2B Q14289 1/20 0.52
▸ ESR2 Q92731 1/20 0.52
▸ NPC1 O15118 8/20 0.51
▸ RAB9A P51151 8/20 0.51
▸ ADRA2A P08913 2/20 0.49
▸ SIRT6 Q8N6T7 1/20 0.49
▸ SMN1; SMN2 Q16637 2/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.48
▸ MEN1 O00255 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ KDM1A O60341 1/20 0.46
▸ GLA P06280 1/20 0.46
▸ SLC2A1 P11166 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27522705 0.80 ADRA2C (0.54) ADRA2CKDM1A
SCHEMBL14922259 0.79 ADRB1 (0.52) ALDH1A1KDM4ESIRT6TSHRKDM1A
SCHEMBL18539269 0.77 ADRA2C (0.64) ALDH1A1ADRA2CGAAKMT2AKDM4E
SCHEMBL2264251 0.77 ADRA2C (0.59) ALDH1A1ADRA2CGAAKMT2AKDM4E
SCHEMBL27773145 0.77 NPC1 (0.40) ALDH1A1ADRA2CKDM4ENPC1RAB9A
SCHEMBL28933198 0.76 NAMPT (0.42) ALDH1A1GAAKMT2AKDM4EMAPT
SCHEMBL5536262 0.75 ALDH1A1 (0.61) ALDH1A1ADRA2CGAAKMT2AKDM4E
SCHEMBL5536255 0.75 NPC1 (0.54) ALDH1A1ADRA2CGAAKMT2AKDM4E
SCHEMBL28743313 0.74 HTR6 (0.45) GAAKMT2AKDM4EMAPTNPC1
SCHEMBL10426116 0.74 ALDH1A1 (0.59) ALDH1A1ADRA2CGAAKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110914234-B Amine compound for inhibiting SSAO/VAP-1 and application thereof in medicine 广东东阳光药业有限公司 2023-06-23 — — CN disclosed
CN-110914234-A Amine compound for inhibiting SSAO/VAP-1 and application thereof in medicine 广东东阳光药业有限公司 2020-03-24 — — CN disclosed
US-RE44205-E1 Adenosine A2a receptor antagonists MERCK SHARP & DOHME CORP. (US) 2013-05-07 — — US disclosed
Send feedback